RecruitingPhase 1NCT07446400
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
Studying Central nervous system malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Intervention
- Repinatrabit(drug)
- Enrollment
- 48 enrolled
- Eligibility
- 18-55 years · All sexes
- Timeline
- 2026 – 2026
Study locations (1)
- Nucleus Network, Melbourne, Victoria, Australia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07446400 on ClinicalTrials.govOther trials for Central nervous system malformation
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06986954Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter StudyCook Research Incorporated
- RECRUITINGNCT06601569Predictors of Range of Motion and Balance Abnormalities in Children Diagnosed with Cerebral PalsyCairo University
- RECRUITINGNANCT06136572Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's SyndromeUniversity Hospital, Clermont-Ferrand
- RECRUITINGNCT03851484Sensory Symptoms in Tourette SyndromeVanderbilt University Medical Center
- RECRUITINGNANCT02119611Deep Brain Stimulation Therapy in Movement DisordersNational Institute of Neurological Disorders and Stroke (NINDS)